These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37550073)

  • 1. Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease.
    McKeon A; Lesnick C; Vorasoot N; Buckley MW; Dasari S; Flanagan EP; Gilligan M; Lafrance-Corey R; Miske R; Pittock SJ; Scharf M; Yang B; Zekeridou A; Dubey D; Mills J
    Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37550073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure-related 6 homolog like 2 autoimmunity: Neurologic syndrome and antibody effects.
    Landa J; Guasp M; Petit-Pedrol M; Martínez-Hernández E; Planagumà J; Saiz A; Ruiz-García R; García-Fernández L; Verschuuren J; Saunders-Pullman R; Ramirez-Gómez L; Geschwind MD; Dalmau J; Sabater L; Graus F
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33144342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune central nervous system disorders: Antibody testing and its clinical utility.
    Gilligan M; McGuigan C; McKeon A
    Clin Biochem; 2024 Apr; 126():110746. PubMed ID: 38462203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG.
    Honorat JA; Lopez-Chiriboga AS; Kryzer TJ; Komorowski L; Scharf M; Hinson SR; Lennon VA; Pittock SJ; Klein CJ; McKeon A
    Neurology; 2019 Sep; 93(10):e954-e963. PubMed ID: 31371564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human neurexin-3α antibodies associate with encephalitis and alter synapse development.
    Gresa-Arribas N; Planagumà J; Petit-Pedrol M; Kawachi I; Katada S; Glaser CA; Simabukuro MM; Armangué T; Martínez-Hernández E; Graus F; Dalmau J
    Neurology; 2016 Jun; 86(24):2235-42. PubMed ID: 27170573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: Anti-neurexin-3α-associated autoimmune encephalitis secondary to contrast-induced encephalopathy.
    Zhu L; Shang Q; Zhao CW; Dai S; Wu Q
    Front Neurol; 2023; 14():1060110. PubMed ID: 36949853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies.
    Hansen N; Lange C; Maass F; Hassoun L; Bouter C; Stöcker W; Schott BH; Wiltfang J; Fitzner D
    Brain Sci; 2021 May; 11(6):. PubMed ID: 34064006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of Seizure-related 6 homolog like 2 (Sez6l2) antibody-associated autoimmune cerebellar ataxia].
    Matsuyama Y; Satake M; Abe M; Yaguchi H; Yabe I
    Rinsho Shinkeigaku; 2023 Oct; 63(10):665-671. PubMed ID: 37779021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEZ6L2 Antibody-Associated Cerebellar Ataxia Responsive to Sequential Immunotherapy.
    Mehdiyeva A; Hietaharju A; Sipilä J
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35031588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity.
    Vorasoot N; Scharf M; Miske R; Thakolwiboon S; Dubey D; Mills JR; Pittock SJ; Zekeridou A; Ott A; McKeon A
    Front Immunol; 2023; 14():1265797. PubMed ID: 37841252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases.
    Weihua Z; Haitao R; Jie D; Changhong R; Ji Z; Anna Z; Hongzhi G; Xiaotun R
    J Neuroimmunol; 2022 Sep; 370():577918. PubMed ID: 35853356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
    Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
    Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia.
    Garza M; Piquet AL
    Front Neurol; 2021; 12():683048. PubMed ID: 34489848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sez6l2 regulates phosphorylation of ADD and neuritogenesis.
    Yaguchi H; Yabe I; Takahashi H; Watanabe M; Nomura T; Kano T; Matsumoto M; Nakayama KI; Watanabe M; Hatakeyama S
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):234-241. PubMed ID: 29032200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune septin-5 cerebellar ataxia.
    Honorat JA; Lopez-Chiriboga AS; Kryzer TJ; Fryer JP; Devine M; Flores A; Lennon VA; Pittock SJ; McKeon A
    Neurol Neuroimmunol Neuroinflamm; 2018 Sep; 5(5):e474. PubMed ID: 29998156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DAGLA as an autoantibody target in cerebellar ataxia.
    Miske R; Scharf M; Borowski K; Specht I; Corty M; Loritz MJ; Rombach F; Laureys G; Rochow N; Radzimski C; Schnitter L; Ratuszny D; Skripuletz T; Wattjes MP; Hahn S; Denno Y; Guerti K; Oyaert M; Benkhadra F; Bien CI; Nitsch S; Wandinger KP; van Pesch V; Probst C; Teegen B; Komorowski L; Sühs KW
    J Neurol Neurosurg Psychiatry; 2024 Apr; ():. PubMed ID: 38663995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-SEZ6L2 antibodies in paraneoplastic cerebellar syndrome: case report and review of the literature.
    Kather A; Holtbernd F; Brunkhorst R; Hasan D; Markewitz R; Wandinger KP; Wiesmann M; Schulz JB; Tauber SC
    Neurol Res Pract; 2022 Oct; 4(1):54. PubMed ID: 36310162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
    Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.